NEWS
You can follow the latest news of MicroViable in this section
Two Projects funded under CanSERV European call
Microviable obtained two projects funded under CanSERV European call focused on "Reaching and Understanding of Cancer". We are proud to announce that our research proposal “Exploring the relationships between anti-PD1 responders and gut microbiota: intervention [...]
Projects awarded SEKUENS
At Microviable we are proud and thankful to SEKUENS, Agencia de Ciencia, Competitividad Empresarial e Innovación del Principado de Asturias, for the four projects approved in 2025 with competitive funding! We will keep pushing for [...]
Pilar Manrique will present at 10th Microbiome Movement Summit
Pilar Manrique, PhD, senior scientist at Microviable Therapeutics will be present at the 10th Microbiome Microbiome Movement Summit taking place in London, in January 28-29th 2026! Pilar Manrique will be presenting on Thursday 29th at [...]
Claudio Hidalgo presenting at LSX Inv€$stival Showcase
Microviable Therapeutics will be attending LSX Inv€$tival Showcase Claudio Hidalgo, PhD, cofounder and CEO and Noelia Martínez, PhD, cofounder and R&D Director at Microviable Therapeutics, will be attending LSX Inv€$tival Showcase in London on November [...]
World Microbiome Day
World Microbiome Day is here another year!! The World Microbiome Day was created for raising awareness about the fascinating world of microbiomes and their impact on our health and the environment. The human microbiome is [...]
Microviable attending BIO 2025
Microviable Therapeutics will be attending Bio International Convention 2025 in Boston Claudio Hidalgo, PhD., cofounder and CEO, will be attending the BIO International Convention 2025 event, taking place in Boston during June 16th-19th. This four-day [...]